Cellular Oncology

Papers
(The H4-Index of Cellular Oncology is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Angiogenesis as a hallmark of solid tumors - clinical perspectives135
Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN77
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities76
The role of tumor-associated macrophages in osteosarcoma progression – therapeutic implications53
Porphyromonas gingivalis promotes tumor progression in esophageal squamous cell carcinoma51
A comprehensive review of SHP2 and its role in cancer50
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities41
MT1JP-mediated miR-24-3p/BCL2L2 axis promotes Lenvatinib resistance in hepatocellular carcinoma cells by inhibiting apoptosis39
Immunosuppression, immune escape, and immunotherapy in pancreatic cancer: focused on the tumor microenvironment37
HDAC6: A unique HDAC family member as a cancer target37
Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma34
Prognostic role of proliferating CD8+ cytotoxic Tcells in human cancers30
Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer30
How VEGF-A and its splice variants affect breast cancer development – clinical implications28
Terminal α2,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells28
Protein arginine methyltransferase 5: a potential cancer therapeutic target28
A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing28
YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin27
Histone deacetylase (HDAC) 9: versatile biological functions and emerging roles in human cancer27
Clinical perspectives of BET inhibition in ovarian cancer26
Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy26
The Duchenne muscular dystrophy gene and cancer26
Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation24
Loss of ARID1A expression promotes lung adenocarcinoma metastasis and predicts a poor prognosis23
Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications23
0.21488499641418